back to top
HomeTagsPharmaceuticals

Pharmaceuticals

Ironwood Prescription drugs shares surge on competitor's woes By Investing.com

Investing.com -- Shares of Ironwood Prescription drugs (NASDAQ:) soared by as a lot as 32% at present, following a major improvement within...

Avadel Prescription drugs director Geoffrey Glass buys shares price $199,640 By Investing.com

Geoffrey Michael Glass, a director at Avadel Prescription drugs PLC (NASDAQ:), lately acquired extra shares of the corporate. In accordance with a Type 4...

Virpax Prescription drugs declares auditor change and board resignation By Investing.com

Virpax Prescription drugs, Inc. (NASDAQ:VRPX), an organization centered on pharmaceutical preparations, reported vital company modifications in a current SEC submitting. On Monday, the corporate's...

Terns Prescription drugs CFO sells $110,000 in firm inventory By Investing.com

Terns Prescription drugs, Inc. (NASDAQ:TERN) Chief Monetary Officer Mark J. Vignola not too long ago engaged in transactions involving the corporate's frequent inventory, in...

ORIC Prescribed drugs Reviews Inducement Grants  below Nasdaq Itemizing Rule 5635(c)(4) By Investing.com

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ORIC Prescribed drugs, Inc. (Nasdaq:ORIC), a medical stage oncology firm targeted...

Jazz Prescribed drugs Declares Pricing of Personal Providing of $850 Million of three.125% Exchangeable Senior Notes due 2030 and Concurrent Peculiar Share Repurchases By...

DUBLIN, Sept. 4, 2024 /PRNewswire/ --  Jazz Prescribed drugs plc (Nasdaq: JAZZ) (" Jazz Pharmaceuticals (NASDAQ:)") as we speak introduced the pricing of...

Cyclacel Prescribed drugs expands fairness incentive plan By Investing.com

Cyclacel Prescribed drugs , Inc. (NASDAQ:), a biopharmaceutical agency, introduced vital company updates following its 2024 Annual Assembly of Stockholders held on June...

Mirum Prescription drugs to Host Investor Name to Share Interim Evaluation Outcomes from the Volixibat VANTAGE and VISTAS research on June 17, 2024 By...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Prescription drugs, Inc. (NASDAQ: MIRM) as we speak introduced that it's going to host an investor name on Monday,...

Most Popular

spot_img